A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...

Migur A, Feussner M, Liao C, Alkhnbashi OS, Chauvier A, Walter NG, Backofen R, Weinberg Z, Beisel CL (2026) A leader-repeat hairpin blocks extraneous CRISPR RNA production in diverse CRISPR-Cas13 ...

European Biotechs are utilizing AI and precision medicines to improve the personalized treatment of cardiovascular disease.

Profs and Pints Northern Virginia presents: "Eugenics Then and Now,” on a dangerous movement in science and its lessons for ...

Deregulation of new GM crops will increase seed market concentration, undermine resilience of the food system. By Corporate ...

The draft guidance supports the agency’s new pathway designed to speed up the development of custom gene therapies.

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...

Behind the viral Rise plushie from NASA's Artemis II mission is a bigger story: the freelancers who made it happen, and how ...

The scientists driving Neion Bio’s effort to engineer chickens as scalable, lower-cost platforms for biologics manufacturing.

Explore the decades-long journey to map the full human genome, from early breakthroughs to the first complete, gapless DNA ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...